In patients in the CKD-stage-4/5 group, male sex (%) and MIS ≥ 8 decreased with an increasing BMI; the eGFR, Hb and triglyceride levels, and percentage of diabetes mellitus and metabolic syndrome increased with an increasing BMI. This evidence concerns the gene GSTM1 and metabolic syndrome.